Delivery Order SPE2DB20D1100-SPE2DB24FB1X0

Award Date 4/9/24
Potential Completion Date 4/10/24
Potential Value $132K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $8,099.96 firm fixed price delivery order is for the supply of 4,563,979,984 tablets of Bupropion HCL XL 150 mg. The contract does not have a set-aside designation and was awarded as part of a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,944.85 firm-fixed-price delivery order is for the supply of 4,564,339,465 units of Bupropion HCL XL 150 mg tablets, with a completion date of April 22, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,732.67 firm-fixed-price delivery order is for the supply of 4,562,816,824 units of Bupropion HCL XL 150 mg tablets. The award has an ultimate completion date of November 15, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $31,648.98 firm fixed price delivery order is for the provision of 4564159083 - BUPROPION HCL XL 300 MG TABLET 500S. The award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was previously awarded to Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,487.12 firm fixed-price delivery order is for the supply of 4,567,379,185 units of Bupropion HCL XL 300 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of Bupropion HCL XL 150 mg tablets in 500-count size, with a ceiling value of $10,602.74 and a period of performance through March 22, 2024. The contract is a firm fixed price delivery order, with no set-aside designation used....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,598.98 firm fixed price delivery order is for the supply of 4,563,970,057 units of the prescription medication Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The $23,494.99 firm fixed-price delivery order is for the supply of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of April 19, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,562,868,973 units of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $94,212.97 and a period of performance through November 21, 2023. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract supports the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of 4,564,534,508 units of Bupropion HCL XL 150 mg Tablets in 500-count bottles. The contract, valued at $19,118.32, has a firm fixed price and a completion date of May 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB1X0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $132,373.95 firm fixed price delivery order is for the supply of 4,564,220,900 units of Bupropion HCL XL 150 mg tablets.

The award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the sole awardee on this IDC.

Generated 7/9/24, 1:43 PM